Find Ozagrel Sodium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 130952-46-4, 189224-26-8, Cataclot, Xanbon, Sodium ozagrel, Ozagrel (sodium)
Molecular Formula
C13H11N2NaO2
Molecular Weight
250.23  g/mol
InChI Key
NCNYJCOBUTXCBR-IPZCTEOASA-M
FDA UNII
4X5577N3ET

Ozagrel Sodium
1 2D Structure

Ozagrel Sodium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate
2.1.2 InChI
InChI=1S/C13H12N2O2.Na/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15;/h1-8,10H,9H2,(H,16,17);/q;+1/p-1/b6-5+;
2.1.3 InChI Key
NCNYJCOBUTXCBR-IPZCTEOASA-M
2.1.4 Canonical SMILES
C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)[O-].[Na+]
2.1.5 Isomeric SMILES
C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)[O-].[Na+]
2.2 Other Identifiers
2.2.1 UNII
4X5577N3ET
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-2-propenoic Acid

2. 4-(1-imidazoylmethyl)cinnamic Acid

3. Oky 046

4. Oky-046

5. Ozagrel

6. Ozagrel, Monohydrochloride

7. Ozagrel, Monohydrochloride, (e)-isomer

8. Sodium Ozagrel

2.3.2 Depositor-Supplied Synonyms

1. 130952-46-4

2. 189224-26-8

3. Cataclot

4. Xanbon

5. Sodium Ozagrel

6. Ozagrel (sodium)

7. Athrombone

8. Kadenin

9. Ozagrel Sodium [jan]

10. Ozagrel Sodium Salt [mi]

11. Sodium (e)-3-(4-((1h-imidazol-1-yl)methyl)phenyl)acrylate

12. Ozagrel Sodium [who-dd]

13. Sodium 3-(4-((1h-imidazol-1-yl)methyl)phenyl)acrylate

14. Kw-01

15. 4x5577n3et

16. 189224-26-8 (sodium)

17. 2-propenoic Acid, 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-, Sodium Salt, (2e)-

18. 2-propenoic Acid, 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-, Sodium Salt, (e)-

19. 2-propenoic Acid, 3-[4-(1h-imidazol-1-ylmethyl)phenyl]-, Sodium Salt (1:1)

20. 2-propenoic Acid, 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-, Sodium Salt (1:1), (2e)-

21. Sodium;(e)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate

22. Unii-4x5577n3et

23. Xanbons

24. Ozapen (tn)

25. Ozagrel Sodium (jp17)

26. Schembl3093220

27. Sodium,3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate

28. Hy-b0428a

29. Amy3367

30. Dtxsid50172327

31. Hms3887a15

32. Bcp12393

33. Ex-a5745

34. Akos015895382

35. Akos015967214

36. Akos025149474

37. Ccg-266963

38. Cs-3808

39. Ac-15516

40. As-12150

41. Gd95350000

42. D01684

43. A912378

44. Oky-046 Sodium;oky 046 Sodium;oky046 Sodium

45. Q27260625

46. Sodium(e)-3-(4-((1h-imidazol-1-yl)methyl)phenyl)acrylate

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 250.23 g/mol
Molecular Formula C13H11N2NaO2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count4
Exact Mass250.07182188 g/mol
Monoisotopic Mass250.07182188 g/mol
Topological Polar Surface Area58 Ų
Heavy Atom Count18
Formal Charge0
Complexity289
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


Fibrinolytic Agents

Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)


Histamine Antagonists

Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)


REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty